(Q89161354)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

title

Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

author name string

P Comeglio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

S Filippi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

E Sarchielli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

A Morelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

I Cellai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

C Corno

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

A Pini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

L Adorini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

G B Vannelli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

M Maggi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

publication date

19 June 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

Journal of Endocrinological Investigation

1 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

page(s)

283-294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

The myofibroblast: a quarter century after its discovery.

1 April 2020

cites work

1 reference

12 December 2020

Mechanisms of myofibroblast activity and phenotypic modulation.

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

1 reference

12 December 2020

Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

12 December 2020

The SLUG zinc-finger protein represses E-cadherin in breast cancer

1 reference

12 December 2020

The myofibroblast in pulmonary fibrosis

1 reference

12 December 2020

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

1 reference

12 December 2020

Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis.

1 reference

12 December 2020

TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

1 reference

12 December 2020

Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic

1 reference

12 December 2020

Complex networks orchestrate epithelial-mesenchymal transitions

1 reference

12 December 2020

Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1

1 reference

12 December 2020

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

1 reference

12 December 2020

Role of bile acids and bile acid receptors in metabolic regulation

1 reference

12 December 2020

Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction

1 reference

12 December 2020

Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model

1 reference

12 December 2020

Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes

1 reference

12 December 2020

Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis

1 reference

12 December 2020

The rising incidence of idiopathic pulmonary fibrosis in the U.K

1 reference

12 December 2020

Antifibrotic activities of pirfenidone in animal models

1 reference

12 December 2020

Metalloproteinases in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Idiopathic pulmonary fibrosis

1 reference

12 December 2020

Modeling pulmonary fibrosis with bleomycin

1 reference

12 December 2020

FXR protects lung from lipopolysaccharide-induced acute injury

1 reference

12 December 2020

Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor

1 reference

12 December 2020

Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis

1 reference

12 December 2020

The impact of TGF-β on lung fibrosis: from targeting to biomarkers

1 reference

12 December 2020

Pro-fibrotic processes in human lung fibroblasts are driven by an autocrine/paracrine endothelinergic system

1 reference

12 December 2020

Strategies for anti-fibrotic therapies

1 reference

12 December 2020

The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice

1 reference

12 December 2020

Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.

1 reference

12 December 2020

Molecular mechanisms of epithelial-mesenchymal transition

1 reference

12 December 2020

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells

1 reference

12 December 2020

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

1 reference

12 December 2020

Endothelial-to-mesenchymal transition in pulmonary hypertension.

1 reference

12 December 2020

Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions

1 reference

12 December 2020

Recent advances in the development of farnesoid X receptor agonists

1 reference

12 December 2020

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy

1 reference

12 December 2020

Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions

1 reference

12 December 2020

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.

1 reference

12 December 2020

Pulmonary Epithelial Cell-Derived Cytokine TGF-β1 Is a Critical Cofactor for Enhanced Innate Lymphoid Cell Function

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history

1 reference

12 December 2020

Treatment of Idiopathic Pulmonary Fibrosis

1 reference

12 December 2020

Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?

1 reference

12 December 2020

Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases

1 reference

12 December 2020

Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension.

1 reference

12 December 2020

Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1.

1 reference

12 December 2020

Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.

1 reference

12 December 2020

Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis

1 reference

12 December 2020

Severe idiopathic pulmonary fibrosis: what can be done?

1 reference

12 December 2020

10.1007/S40618-018-0913-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29923060%20AND%20SRC:MED&resulttype=core&format=json

1 April 2020

1 reference